BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30840881)

  • 1. Comprehensive Genomic Analysis Reveals that the Pioneering Function of FOXA1 Is Independent of Hormonal Signaling.
    Glont SE; Chernukhin I; Carroll JS
    Cell Rep; 2019 Mar; 26(10):2558-2565.e3. PubMed ID: 30840881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXA1 is a key determinant of estrogen receptor function and endocrine response.
    Hurtado A; Holmes KA; Ross-Innes CS; Schmidt D; Carroll JS
    Nat Genet; 2011 Jan; 43(1):27-33. PubMed ID: 21151129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer.
    Fu X; Jeselsohn R; Pereira R; Hollingsworth EF; Creighton CJ; Li F; Shea M; Nardone A; De Angelis C; Heiser LM; Anur P; Wang N; Grasso CS; Spellman PT; Griffith OL; Tsimelzon A; Gutierrez C; Huang S; Edwards DP; Trivedi MV; Rimawi MF; Lopez-Terrada D; Hilsenbeck SG; Gray JW; Brown M; Osborne CK; Schiff R
    Proc Natl Acad Sci U S A; 2016 Oct; 113(43):E6600-E6609. PubMed ID: 27791031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid Receptors Reprogram FoxA1 Occupancy through Dynamic Chromatin Transitions.
    Swinstead EE; Miranda TB; Paakinaho V; Baek S; Goldstein I; Hawkins M; Karpova TS; Ball D; Mazza D; Lavis LD; Grimm JB; Morisaki T; Grøntved L; Presman DM; Hager GL
    Cell; 2016 Apr; 165(3):593-605. PubMed ID: 27062924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of double-positive FOXA1 and FOXP1 immunoreactivities with favorable prognosis of tamoxifen-treated breast cancer patients.
    Ijichi N; Shigekawa T; Ikeda K; Horie-Inoue K; Shimizu C; Saji S; Aogi K; Tsuda H; Osaki A; Saeki T; Inoue S
    Horm Cancer; 2012 Aug; 3(4):147-59. PubMed ID: 22476979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXA1 Reprogramming Dictates Retinoid X Receptor Response in ESR1-Mutant Breast Cancer.
    Wu Y; Li Z; Wedn AM; Casey AN; Brown D; Rao SV; Omarjee S; Hooda J; Carroll JS; Gertz J; Atkinson JM; Lee AV; Oesterreich S
    Mol Cancer Res; 2023 Jun; 21(6):591-604. PubMed ID: 36930833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More on FOX News: FOXA1 on the horizon of estrogen receptor function and endocrine response.
    Fu X; Huang C; Schiff R
    Breast Cancer Res; 2011 Apr; 13(2):307. PubMed ID: 21575280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXA1 Mutations Reveal Distinct Chromatin Profiles and Influence Therapeutic Response in Breast Cancer.
    Arruabarrena-Aristorena A; Maag JLV; Kittane S; Cai Y; Karthaus WR; Ladewig E; Park J; Kannan S; Ferrando L; Cocco E; Ho SY; Tan DS; Sallaku M; Wu F; Acevedo B; Selenica P; Ross DS; Witkin M; Sawyers CL; Reis-Filho JS; Verma CS; Jauch R; Koche R; Baselga J; Razavi P; Toska E; Scaltriti M
    Cancer Cell; 2020 Oct; 38(4):534-550.e9. PubMed ID: 32888433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of Forkhead box protein A1 (FOXA1) leads to cancer stem cell-like properties in tamoxifen-resistant breast cancer cells through induction of interleukin-6.
    Yamaguchi N; Nakayama Y; Yamaguchi N
    J Biol Chem; 2017 May; 292(20):8136-8148. PubMed ID: 28270510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonlinear relationship between chromatin accessibility and estradiol-regulated gene expression.
    Chen D; Parker TM; Bhat-Nakshatri P; Chu X; Liu Y; Wang Y; Nakshatri H
    Oncogene; 2021 Feb; 40(7):1332-1346. PubMed ID: 33420376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-regulation between FOXA1 and ErbB2 signaling in estrogen receptor-negative breast cancer.
    Naderi A; Meyer M; Dowhan DH
    Neoplasia; 2012 Apr; 14(4):283-96. PubMed ID: 22577344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analyses of an epigenetic switch involved in the activation of pioneer factor FOXA1 leading to the prognostic value of estrogen receptor and FOXA1 co-expression in breast cancer.
    Jing X; Liang H; Hao C; Hongxia L; Cui X
    Aging (Albany NY); 2019 Sep; 11(18):7442-7456. PubMed ID: 31562808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A transcriptional complex composed of ER(α), GATA3, FOXA1 and ELL3 regulates IL-20 expression in breast cancer cells.
    Lee JY; Park YJ; Oh N; Kwack KB; Park KS
    Oncotarget; 2017 Jun; 8(26):42752-42760. PubMed ID: 28514748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cooperativity of co-factor NR2F2 with Pioneer Factors GATA3, FOXA1 in promoting ERα function.
    Jiang G; Wang X; Sheng D; Zhou L; Liu Y; Xu C; Liu S; Zhang J
    Theranostics; 2019; 9(22):6501-6516. PubMed ID: 31588232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphenol A stimulates the epithelial mesenchymal transition of estrogen negative breast cancer cells via FOXA1 signals.
    Zhang XL; Wang HS; Liu N; Ge LC
    Arch Biochem Biophys; 2015 Nov; 585():10-16. PubMed ID: 26363213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine Phosphorylation of the Pioneer Transcription Factor FoxA1 Promotes Activation of Estrogen Signaling.
    Yamaguchi N; Shibazaki M; Yamada C; Anzai E; Morii M; Nakayama Y; Kuga T; Hashimoto Y; Tomonaga T; Yamaguchi N
    J Cell Biochem; 2017 Jun; 118(6):1453-1461. PubMed ID: 27883218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ELF5 modulates the estrogen receptor cistrome in breast cancer.
    Piggin CL; Roden DL; Law AMK; Molloy MP; Krisp C; Swarbrick A; Naylor MJ; Kalyuga M; Kaplan W; Oakes SR; Gallego-Ortega D; Clark SJ; Carroll JS; Bartonicek N; Ormandy CJ
    PLoS Genet; 2020 Jan; 16(1):e1008531. PubMed ID: 31895944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXA1 Directs H3K4 Monomethylation at Enhancers via Recruitment of the Methyltransferase MLL3.
    Jozwik KM; Chernukhin I; Serandour AA; Nagarajan S; Carroll JS
    Cell Rep; 2016 Dec; 17(10):2715-2723. PubMed ID: 27926873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleation of DNA repair factors by FOXA1 links DNA demethylation to transcriptional pioneering.
    Zhang Y; Zhang D; Li Q; Liang J; Sun L; Yi X; Chen Z; Yan R; Xie G; Li W; Liu S; Xu B; Li L; Yang J; He L; Shang Y
    Nat Genet; 2016 Sep; 48(9):1003-13. PubMed ID: 27500525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-specific mutation of GATA3 disrupts the transcriptional regulatory network governed by Estrogen Receptor alpha, FOXA1 and GATA3.
    Takaku M; Grimm SA; De Kumar B; Bennett BD; Wade PA
    Nucleic Acids Res; 2020 May; 48(9):4756-4768. PubMed ID: 32232341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.